Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / OCDX - Ortho Clinical Diagnostics launches COVID-19 antibody tests

OCDX - Ortho Clinical Diagnostics launches COVID-19 antibody tests

Ortho Clinical Diagnostics plc
Ortho Clinical Diagnostics (OCDX) announces the launch of its quantitative COVID-19 IgG antibody test in addition to a total COVID-19 nucleocapsid antibody test.Both tests help in differentiating the cause of antibodies against SARS-CoV-2 and are processed on Ortho's VITROS Systems.Ortho's new IgG quantitative test is intended for the qualitative and quantitative measurement of IgG antibodies to SARS-CoV-2 in human serum and plasma.The VITROS Anti-SARS-CoV-2 Total Nucleocapsid Antibody Test is a test for the qualitative detection of SARS-CoV-2 nucleocapsid antibodies in patients who have been infected with the virus.

For further details see:

Ortho Clinical Diagnostics launches COVID-19 antibody tests
Stock Information
Company Name: Ortho Clinical Diagnostics plc
Stock Symbol: OCDX
Market: NASDAQ
Website: orthoclinicaldiagnostics.com
Menu
OCDX OCDX Quote OCDX Short OCDX News OCDX Articles OCDX Message Board
Get OCDX Alerts

News, Short Squeeze, Breakout and More Instantly...